ArticleTranslational cancer research2021

The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis.

Geng-Wei Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.